6-((1R,2R,3AS,9AS)-5-(CARBOXYMETHOXY)-2-HYDROXY-2,3,3A,4,9,9A-HEXAHYDRO-1H-CYCLOPENTA(B)NAPHTHALEN-1-YL)HEX-3-ENOIC ACID, (E)-
UNII 3PE8S99ZTG
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((1r,2r,3as,9as)-5-(carboxymethoxy)-2-hydroxy-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta(b)naphthalen-1-yl)hex-3-enoic Acid, (e)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3PE8S99ZTG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H26O6 NVTIWSLEXNPHQF-BNNKELBSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((1r,2r,3as,9as)-5-(carboxymethoxy)-2-hydroxy-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta(b)naphthalen-1-yl)hex-3-enoic Acid, (e)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.